AdvanCell

AdvanCellAdvanCell
AdvanCell

AdvanCell

Advancing targeted alpha therapies.

ActiveBoston, USA
Rate

About

AdvanCell provides innovative thermo-expandable microspheres, primarily Advancell Expandable Microspheres (EM), which are acrylic shells activated by heat for foam, adhesion, and texturing applications. These microspheres are utilized across various industries including building materials, automobiles, and lifestyle goods to create lighter, more flexible products with high-quality finishes. AdvanCell serves manufacturers and product developers seeking advanced material solutions.

Technology stack

detected 2026-07-15
Email
gateway-fronted
Hosting
Stack
Analytics
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does AdvanCell do?

AdvanCell provides innovative thermo-expandable microspheres, primarily Advancell Expandable Microspheres (EM), which are acrylic shells activated by heat for foam, adhesion, and texturing applications. These microspheres are utilized across various industries including building materials, automobiles, and lifestyle goods to create lighter, more flexible products with high-quality finishes. AdvanCell serves manufacturers and product developers seeking advanced material solutions.

How much funding has AdvanCell raised?

AdvanCell has raised a total of $315M in funding. The most recent round on record is Series D.

Where is AdvanCell headquartered?

AdvanCell is headquartered in Boston, USA.

What industry does AdvanCell operate in?

AdvanCell operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials.

What is AdvanCell's revenue?

StartupHub estimates AdvanCell's annual revenue at $38.5M (range $10.2M to $119.7M, 37% confidence), based on comparable companies in the sector.

What is AdvanCell's valuation?

StartupHub estimates AdvanCell's effective valuation at $1.2B (range $787.5M to $1.9B, 25% confidence), based on comparable companies in the sector.